Bosserhoff AK - Search Results

1

Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.

Hau P, Ruemmele P, Kunz-Schughart LA, Doerfelt A, Hirschmann B, Lohmeier A, Koch H, Mueller A, Bogdahn U, Bosserhoff AK. Hau P, et al. Among authors: bosserhoff ak. Oncol Rep. 2004 Dec;12(6):1355-64. Oncol Rep. 2004. PMID: 15547763

2

Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA.

Blesch A, Bosserhoff AK, Apfel R, Behl C, Hessdoerfer B, Schmitt A, Jachimczak P, Lottspeich F, Buettner R, Bogdahn U. Blesch A, et al. Among authors: bosserhoff ak. Cancer Res. 1994 Nov 1;54(21):5695-701. Cancer Res. 1994. PMID: 7923218

3

Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIA.

Bosserhoff AK, Hein R, Bogdahn U, Buettner R. Bosserhoff AK, et al. J Biol Chem. 1996 Jan 5;271(1):490-5. doi: 10.1074/jbc.271.1.490. J Biol Chem. 1996. PMID: 8550608 Free article.

4

Assignment of the human melanoma inhibitory activity gene (MIA) to 19q13.32-q13.33 by fluorescence in situ hybridization (FISH).

Koehler MR, Bosserhoff A, von Beust G, Bauer A, Blesch A, Buettner R, Schlegel J, Bogdahn U, Schmid M. Koehler MR, et al. Genomics. 1996 Jul 1;35(1):265-7. doi: 10.1006/geno.1996.0352. Genomics. 1996. PMID: 8661134 No abstract available.

5

Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma.

Bosserhoff AK, Kaufmann M, Kaluza B, Bartke I, Zirngibl H, Hein R, Stolz W, Buettner R. Bosserhoff AK, et al. Cancer Res. 1997 Aug 1;57(15):3149-53. Cancer Res. 1997. PMID: 9242442

6

In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid.

Jacob K, Wach F, Holzapfel U, Hein R, Lengyel E, Buettner R, Bosserhoff AK. Jacob K, et al. Among authors: bosserhoff ak. Melanoma Res. 1998 Jun;8(3):211-9. doi: 10.1097/00008390-199806000-00003. Melanoma Res. 1998. PMID: 9664142

7

[MIA ("melanoma inhibitory activity"). Biological functions and clinical relevance in malignant melanoma].

Bosserhoff AK, Golob M, Buettner R, Landthaler M, Hein R. Bosserhoff AK, et al. Hautarzt. 1998 Oct;49(10):762-9. doi: 10.1007/s001050050822. Hautarzt. 1998. PMID: 9857251 Review. German.

8

Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas.

Glaessl A, Bosserhoff AK, Buettner R, Hohenleutner U, Landthaler M, Stolz W. Glaessl A, et al. Among authors: bosserhoff ak. Arch Dermatol Res. 1999 Feb-Mar;291(2-3):81-7. doi: 10.1007/s004030050387. Arch Dermatol Res. 1999. PMID: 10195394

9

MIA (melanoma inhibitory activity): a potential serum marker for rheumatoid arthritis.

Müller-Ladner U, Bosserhoff AK, Dreher K, Hein R, Neidhart M, Gay S, Schölmerich J, Buettner R, Lang B. Müller-Ladner U, et al. Among authors: bosserhoff ak. Rheumatology (Oxford). 1999 Feb;38(2):148-54. doi: 10.1093/rheumatology/38.2.148. Rheumatology (Oxford). 1999. PMID: 10342628

10

Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.

Mühlbauer M, Langenbach N, Stolz W, Hein R, Landthaler M, Buettner R, Bosserhoff AK. Mühlbauer M, et al. Among authors: bosserhoff ak. Clin Cancer Res. 1999 May;5(5):1099-105. Clin Cancer Res. 1999. PMID: 10353744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters